These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 14999228

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Modulation of retrovirally driven therapeutic genes by mutant TP53 in anaplastic thyroid carcinoma.
    Barzon L, Gnatta E, Castagliuolo I, Trevisan M, Moretti F, Pontecorvi A, Boscaro M, Palù G.
    Cancer Gene Ther; 2005 Apr; 12(4):381-8. PubMed ID: 15650765
    [Abstract] [Full Text] [Related]

  • 23. Liver-directed gene therapy: a retroviral vector with a complete LTR and the ApoE enhancer-alpha 1-antitrypsin promoter dramatically increases expression of human alpha 1-antitrypsin in vivo.
    Okuyama T, Huber RM, Bowling W, Pearline R, Kennedy SC, Flye MW, Ponder KP.
    Hum Gene Ther; 1996 Mar 20; 7(5):637-45. PubMed ID: 8845389
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. High frequency expression of integrated proviruses derived from enhancer trap retroviruses.
    Sablitzky F, Jönsson JI, Cohen BL, Phillips RA.
    Cell Growth Differ; 1993 Jun 20; 4(6):451-9. PubMed ID: 8373730
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Bone marrow mesenchymal cells for haemophilia A gene therapy using retroviral vectors with modified long-terminal repeats.
    Van Damme A, Chuah MK, Dell'accio F, De Bari C, Luyten F, Collen D, VandenDriessche T.
    Haemophilia; 2003 Jan 20; 9(1):94-103. PubMed ID: 12558785
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Retroviral vectors for the transduction of autoregulated, bidirectional expression cassettes.
    Unsinger J, Kröger A, Hauser H, Wirth D.
    Mol Ther; 2001 Nov 20; 4(5):484-9. PubMed ID: 11708885
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. B-cell-specific transgene expression using a self-inactivating retroviral vector with human CD19 promoter and viral post-transcriptional regulatory element.
    Werner M, Kraunus J, Baum C, Brocker T.
    Gene Ther; 2004 Jun 20; 11(12):992-1000. PubMed ID: 15029232
    [Abstract] [Full Text] [Related]

  • 37. Pathogenesis of replication competent retroviruses derived from mouse cells in immunosuppressed primates: implications for use of neoplastic cells as vaccine substrates.
    Purcell DF.
    Dev Biol (Basel); 2001 Jun 20; 106():187-98; discussion 199, 253-63. PubMed ID: 11761231
    [Abstract] [Full Text] [Related]

  • 38. Self-inactivating retroviral vector-mediated gene transfer induces oncogene activation and immortalization of primary murine bone marrow cells.
    Bosticardo M, Ghosh A, Du Y, Jenkins NA, Copeland NG, Candotti F.
    Mol Ther; 2009 Nov 20; 17(11):1910-8. PubMed ID: 19638958
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Reducing the genotoxic potential of retroviral vectors.
    Ramezani A, Hawley TS, Hawley RG.
    Methods Mol Biol; 2008 Nov 20; 434():183-203. PubMed ID: 18470646
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.